by McMaster University Credit: Pixabay/CC0 Public Domain Women and men share most of the same risk factors for cardiovascular disease (CVD), a large international study has found—the first such study to include people not only from high income countries, but also from low- and middle-income countries where the burden of CVD is the greatest. The...
Monkeypox may be linked to encephalitis or confusion in some patients
by University College London Colorized transmission electron micrograph of monkeypox virus particles (red) cultivated and purified from cell culture. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID Monkeypox can sometimes lead to neurological complications such as encephalitis (brain inflammation), confusion or seizures, finds a new review of evidence...
Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows
by Hong Kong University of Science and Technology The figure shows that, for two example proteins that are targeted by VACV-vaccine-induced antibodies, the 2022 monkeypox virus (MPXV-2022) does not comprise any new mutations relative to the previously observed monkeypox virus (MPXV-CB). Credit: HKUST & UoM New research has suggested that recommended vaccinia virus (VACV)-based vaccines...
EVEN MILD COVID HAS LINGERING EFFECTS ON YOUNG ADULTS
As a result, they may be more likely to develop metabolic disorders and cardiovascular complications in the long term. The intermediate-term and long-term effects of SARS-CoV-2 infections on young adults have scarcely been investigated. Available original research tends to focus on sufferers who were hospitalized, elderly, or who have multiple morbidities. Or, existing research restricts evaluations to...
Unique light-sensing 3D-printed device could help people with lupus
UNIVERSITY OF MINNESOTA IMAGE: A UNIQUE 3D-PRINTED LIGHT-SENSING MEDICAL DEVICE COULD HELP MILLIONS OF PEOPLE WORLDWIDE WITH LUPUS AND OTHER LIGHT-SENSITIVE DISEASES BY PROVIDING ACCESS TO REAL-TIME DATA FOR MORE PERSONALIZED TREATMENTS. CREDIT: MCALPINE GROUP, UNIVERSITY OF MINNESOTA MINNEAPOLIS / ST. PAUL (09/08/2022) — A team of engineers and doctors at the University of Minnesota Twin...
Study identifies key protein that drives rheumatoid arthritis damage
WASHINGTON STATE UNIVERSITY SPOKANE, Wash. – Scientists have identified a protein known as sulfatase-2 that plays a critical role in the damage caused by rheumatoid arthritis. A chronic disease in which the immune system attacks the body’s own joint tissues, rheumatoid arthritis affects an estimated 1.5 million Americans. Published in the journal Cellular & Molecular Immunology, the...
Questions to Ask Once Dating a great Asian Lover
When internet dating an asian lady, it is crucial to know what questions to check with her and which ones in order to avoid. This will make certain you don’t make a mistake and land in a misconception. How to Approach an Asian Girlfriend When you are a first-timer with a great Asian lady, you...
Children with condition that causes temporary facial paralysis can recover without treatment
MURDOCH CHILDRENS RESEARCH INSTITUTE Most children with a condition that causes a temporary weakness or paralysis of the muscles in the face recover without medication within six months, according to a new study. The research, led by the Murdoch Children’s Research Institute and published in Neurology, found the steroid prednisolone does not significantly impact on a child’s recovery...
Schizophrenia and bipolar disorder may be detectable years before illnesses begin
by University College Dublin Credit: Pixabay/CC0 Public Domain The risk of schizophrenia and bipolar disorder may be detectable years before the illnesses begin, according to new research. A University College Dublin led study funded by the Health Research Board has found that 50% of people who developed these mental health disorders had attended specialist child and adolescent...
FDA panel backs much-debated ALS drug in rare, 2nd review
by MATTHEW PERRONE This 2018 photo provided by Amylyx shows the company’s co-founders Joshua Cohen, left, and Justin Klee in Cambridge, Mass. on Sept. 2, 2022. A closely watched experimental drug for Lou Gehrig’s disease is getting an unusual second look from U.S. regulators on Wednesday, Sept. 7, 2022, amid intense pressure to approve the...